Skip to main content
OpenTrials
Completed

NCT Number: NCT02792569

Follicle Activation by Inhibition of the Hippo Pathway

The aim of this project is to activate recruitment and growth of resting primordial follicles in the ovaries of women with diminished ovarian reserve, in attempt to increase the chance to become pregnant, either naturally or after assisted reproduction.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–39 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

The Fertility Clinic, Rigshospitalet, Copenhagen University Hospital

Copenhagen, 2100, Denmark

About this study

For this study investigators will carefully select 20 women with low AMH and imminent POI.

They will be randomized to have cortical ovarian biopsies taken from either the left or right ovary. The biopsies will be fragmented in 1x1 mm2 pieces and immediately auto-transplanted in a peritoneal pocket under the right ovary.

The contralateral untouched ovary will act as the control, making each woman their own control.

Follow up: each week in 2,5 months the women will be assessed by transvaginal ultrasound and hormonal status. After 2,5-6 months the women will receive a FSH stimulation cycle (rFSH 300 IU or Corifollitropin) followed by standard IVF/ICSI,

Hypothesis: the ovaries contain a pool of resting primordial follicles. By fragmentation of cortical ovarian tissue, manipulation of the local environment in the tissue will inhibit the Hippo Pathway and hereby active recruitment and growth of primordial follicles.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Infertility with indication for IVF/ICSI
  • Imminent POI, still cycling
  • Age 25 - 39 years
  • Two ovaries
  • Serum AMH measurements < 5 pmol/l (two independent measurements)
  • Antral follicle count (AFC) (sum of both ovaries < 5)

Exclusion criteria

  • Ovarian pathology (endometriosis, cysts)
  • Known chromosomal abnormality
  • Known autoimmune disease (except TPO-antibodies)
  • Patients who have contraindication for laparoscopy

Treatment and study plan

Biopsy of ovarian cortical tissue

Procedure

Biopsies will be taken from either right or left side. The cortical tissue will be isolated and fragmented in 1x1 mm2 pieces, followed by auto-transplantation to a peritoneal pocket.

Primary outcomes

  1. Number of follicles > 12 mm

    Time frame: Up to 6 month after the auto-transplantation

    Number of follicles > 12 mm in response to controlled ovarian stimulation with corifollitropin from the biopsied ovary versus the contralateral untreated ovary

Secondary outcomes

  1. Side of ovulation

    Time frame: Up to 6 months after auto-transplantation

    Frequency of ovulations occurring at the "biopsy side" versus the contralateral side in the subsequent 4- 6 months

Other outcomes

  1. AFC count

    Time frame: Up to 10 month after auto-transplantation

    Number of antral follicles (AFC) at the biopsy side versus that of the contralateral side

  2. AMH changes

    Time frame: Up up to 10 month after auto-transplantation

    Changes (increase - decrease) in serum AMH over time, using the highly sensitive new AMH Assay (Elecsys Assay; Roche), which has been implemented as a routine analysis at The Department of Clinical Biochemistry Rigshospitalet in June 1st 2015

  3. Pregnancy

    Time frame: Through study completion, an average of 1 year

    Numbers of pregnancies (spontaneously/assisted)

Sponsors and collaborators

Lead sponsor

Anders Nyboe Andersen

Other

Registry information

Official study title

Auto-transplantation of Fragmented Ovarian Cortical Tissue in Infertile Patients With Premature Ovarian Oocyte Depletion - a Study to Promote Follicular Activation and Subsequent Fertility

Important dates

Study start
2016
Primary completion
2018
Study completion
2019
First posted
Jun 7, 2016
Registry last updated
Jan 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.